(Bloomberg) — The bounty hunter of Wall Street has finally met his match.
Andrew Left, who’s taken on everything from drug companies to Chinese real estate firms, said his Citron Research will no longer publish short selling research, ending the firm’s two-decade run as one of Wall Street’s best-known contrarians.
Citron will instead focus on what may seem like the only logical move in a world of ever-rising equity markets and low interest rates: long bets.
“Twenty years ago I started…
Source link
